Thursday, December 16, 2004
Time (EST) Track 1                                Track 2 
8:00 a.m. Continental Breakfast 
 
9:00 a.m. Alexion Pharmaceuticals, Inc. (ALXN)    Inhibitex, Inc. (INHX)
eculizumab (PNH) & pexelizumab (CABG)             Veronate (nosocomial infections in neonates)
 
 
9:30 p.m. Transkaryotic Therapies, Inc. (TKTX)    Cell Therapeutics, Inc. (CTIC)
I2S (Hunter syndrome)                             XYOTAX (non-small cell lung cancer) 

 
10:00 a.m. Myogen, Inc. (MYOG)                    Cypress Bioscience, Inc. (CYPB)
enoximone (congestive heart failure)              milnacipran (fibromyalgia) 

 
10:30 a.m. Break 
 
11:00 a.m. Nabi Biopharmaceuticals (NABI)         *Progenics Pharmaceuticals, Inc. (PGNX)
StaphVAX (Staph aureus infection)                 methylnaltrexone (opioid induced bowel dysfunction)
 
 
11:30 a.m. Encysive Pharmaceuticals Inc. (ENCY)    *Dendreon Corporation (DNDN)
Thelin (pulmonary arterial hypertension)           Provenge (hormone refractory prostate cancer)
 
 

* Company declined to be webcasted